Phoenix Biotech Acq -CW26CEROWPreferred / convertible
13F holders, Q4 2025 (December 31)1holders −21
0new positions
21sold out
$0.01avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Phoenix Biotech Acq -CW26 (CEROW) in their 13F filings, down 21 from Q3 2025. 0 opened new positions and 21 sold out. The largest holder was Ancora Advisors LLC ($22).
- Company
- Phoenix Biotech Acq -CW26
- Filed as
- WTS PHOENIX BIOTECH ACQUISITIO (Q4 2025)
- CUSIP
- 71902K113
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 21 | $38K |
All 13F filers, Q3 2025 → Q4 2025: 2,841,392 shares sold, net −2,841,392 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ancora Advisors LLC | — | No change | 2,500 | $22 |
"% of holder's portfolio" is CEROW's weight in each manager's 13F, not the share of Phoenix Biotech Acq -CW26 the manager owns.